Peter D. Kiernan III

This profile gathers the share dealings of Peter D. Kiernan III in Javelin Pharmaceuticals, Inc. Over a trading history stretching from 19 February 2008 to 2 July 2010, the count stands at 45 filings.

No open-market sale appears; the market trades are 44 purchases worth €314k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

A typical purchase (the median) is worth €2,291.

The latest filing, published on 2 July 2010, reports a transaction of €4.2M in Javelin Pharmaceuticals, Inc. The clock since the last published purchase (27 February 2008) now reads 6,814 days. Filings reach the SEC (Form 4) feed a median of 8 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.